Back

Clinical differences between methamphetamine and non-methamphetamine associated non-ischemic dilated cardiomyopathy.

2 September 2019 (15:45 - 16:35)
Organised by:
Congress Presentation Part of: Neuropsychiatric disease, substance abuse and the heart Substance Abuse and Cardiovascular Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Edward Chau

Scripps Clinic, San Diego (United States of America)

6 More presentations in this session

Presentation thumbnail
Atrial fibrillation in elderly patients with syncope and dementia: clinical insights from a large multicenter Italian registry
Slides
Presentation thumbnail
Impaired left ventricular systolic function in alcohol abusers expressed by both 3D calculated ejection fraction and longitudinal strain by AFI.
Doctor P. Hamala (Lodz, PL)
Abstract Slides
Presentation thumbnail
Patients with psychiatric disorders have reduced chances of receiving optimal post-arrest cardiovascular management
Doctor C. Barcella (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Neurogenic stunned myoacardium in multiple sclerosis patients
Doctor E. Tsougos (Athens, GR)
Abstract Slides
Presentation thumbnail
Initiation of oral anticoagulation therapy in atrial fibrillation patients with schizophrenia: a nationwide cohort study
Mrs A. Hojen (Aalborg, DK)
Abstract Slides

Access the full session

Session thumbnail
Neuropsychiatric disease, substance abuse and the heart

The Event

Event poster

ESC Congress 2019

2 September 2019 15:45 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources